The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor ...

The new targeted pipeline will advance Nxera’s oral GLP-1 agonists, novel GPCR targets, and structure-based drug design to ...

Accusing doctors of “dishing out” medications for weight loss and then labelling people “cheats” for using them is a ...

Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

The television presenter was at the helm of Operation Transformation for 14 years, and while the popular RTE show has come to ...

Shares of WW International Inc., the company known as WeightWatchers, reversed their early gains Monday despite better-than-expected second-quarter revenue amid robust demand for GLP-1 obesity ...

Overview As demand for GLP-1 drugs continues to skyrocket, federal and state agencies are turning their attention to the GLP-1 market and ramping up efforts to address the perceived risks associated ...

Shares of WW International Inc., the company known as WeightWatchers, pared back their early gains Monday despite better-than-expected second-quarter revenue amid robust demand for GLP-1 obesity ...

Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an ...

GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...

(HealthDay News) — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according ...